A biotech billionaire’s latest drug bet implodes

March 27, 2013

Biotech investor R.J. Kirk became a billionaire thanks to big bets on two neuroscience drugs: Vyvanse, for attention deficit hyperactivity disorder, and Viibryd, for depression. (Forbes)